Skip to main content

and
  1. Article

    Community-integrated self-collected HPV-based cervix screening in a low-resource rural setting: a pragmatic, cluster-randomized trial

    Effective approaches to improve coverage of self-collected human papillomavirus (HPV)-based cervix screening (SCS) as well as attendance at treatment for HPV-positive participants are needed to inform policy o...

    Anna Gottschlich, Beth A. Payne, Jessica Trawin, Arianne Albert in Nature Medicine (2023)

  2. Article

    Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada

    COVID-19 vaccination is recommended for people living with HIV (PLWH), among whom social inequities and co-morbidities may drive risks of COVID-19 infection and outcome severity. Among a provincial (British Co...

    Angela Kaida, Lori A. Brotto, Melanie C. M. Murray, Hélène C. F. Côté in AIDS and Behavior (2022)

  3. Article

    Open Access

    Intention to receive a COVID-19 vaccine: results from a population-based survey in Canada

    The success of any COVID-19 vaccine program ultimately depends on high vaccine uptake. This study determined overall intention to receive a COVID-19 vaccine and identified factors that predict intentions to be...

    Gina S. Ogilvie, Shanlea Gordon, Laurie W. Smith, Arianne Albert in BMC Public Health (2021)

  4. Article

    Open Access

    Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial

    The HPV FOCAL Trial is a RCT comparing human papilloma virus (HPV) with Liquid Based Cytology (LBC) screening for cervical cancer. Results are presented for the comparison of the Safety and Control arms after ...

    Andrew J Coldman, Lovedeep Gondara, Laurie W Smith in British Journal of Cancer (2016)

  5. Article

    Open Access

    Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval

    High-risk HPV DNA testing has been proposed as a primary tool for cervical cancer screening (HPV-CCS) as an alternative to the Papanicolaou cytology- method. This study describes factors associated with women’...

    Gina S. Ogilvie, Laurie W. Smith, Dirk van Niekerk, Fareeza Khurshed in BMC Public Health (2016)

  6. Article

    Open Access

    Comparison of the Roche cobas® 4800 and Digene Hybrid Capture® 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial

    HPV FOCAL is a randomized trial (ISRCTN79347302, registered 20 Apr 2007) comparing high-risk (hr) HPV testing vs. liquid-based cytology (LBC) for cervical cancer screening of women aged 25–65. We compared the ...

    Darrel A. Cook, Wendy Mei, Laurie W. Smith, Dirk J. van Niekerk in BMC Cancer (2015)

  7. Article

    Open Access

    Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program

    Mounting evidence affirms HPV testing as an effective cervical cancer screening tool, and many organized screening programs are considering adopting it as primary testing. HPV self-collection has comparable se...

    Laurie W Smith, Fareeza Khurshed, Dirk J van Niekerk, Mel Krajden in BMC Public Health (2014)

  8. Article

    Open Access

    A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial)

    In the HPV FOCAL trial, we will establish the efficacy of hr-HPV DNA testing as a stand-alone screening test followed by liquid based cytology (LBC) triage of hr-HPV-positive women compared to LBC followed by ...

    Gina S Ogilvie, Dirk J van Niekerk, Mel Krajden, Ruth E Martin in BMC Cancer (2010)